The Carter Treatment Center

The Carter Treatment Center, based in Alpharetta, GA, is one of the SAMHSA-registered treatment programs operating in GA. The facility offers a continuum of care across multiple levels — PHP, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at The Carter Treatment Center

The care-level question matters because what a facility offers is what it can realistically treat well. The facility offers a continuum of care across multiple levels — PHP, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether The Carter Treatment Center's offerings match the clinical need.

Insurance and payment

On insurance specifically: The Carter Treatment Center accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Before you call

The three questions that consistently separate programs worth considering from programs worth skipping: ASAM level of care match; written VOB for your plan; MAT policy. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Programs that cannot answer all three quickly are programs worth approaching with caution.